STRATA Skin Sciences Appoints Medical Device Commercial Leader Erica Jordan as Chief Executive Officer
STRATA Skin Sciences appointed industry veteran Erica Jordan as Chief Executive Officer, effective July 12, 2026, succeeding Dr. Dolev Rafaeli. Jordan brings extensive experience from Revance Therapeutics and Envista Holdings, where she led commercial operations and strategy. The new CEO's primary mandate is to scale the commercial organization and translate expanded CPT Code coverage into revenue growth.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.